Pamela Esposito

Insider Reports History

Location
Woburn, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pamela Esposito:

Company Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Chief Business Officer Common Stock 263,436 $2,876,721 $10.92 12 Sep 2023 Direct
Kymera Therapeutics, Inc. Director Common Stock 0 $0 $68.52 20 Jan 2026 Direct
Replimune Group, Inc. Chief Business Officer Employee Stock Option (right to buy) 86,033 12 Sep 2023 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 5,000 20 Jan 2026 Direct

Insider Reports Filed by Pamela Esposito

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 20 Jan 2026 7 -$157,171 4 Director 20 Jan 2026, 18:30
KYMR Kymera Therapeutics, Inc. 17 Dec 2025 10 -$1,221,997 4 Director 17 Dec 2025, 18:07
KYMR Kymera Therapeutics, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 21:00
KYMR Kymera Therapeutics, Inc. 03 Jun 2025 3 -$97,436 4 Director 03 Jun 2025, 18:30
KYMR Kymera Therapeutics, Inc. 02 Dec 2024 3 -$48,625 4 Director 02 Dec 2024, 19:50
KYMR Kymera Therapeutics, Inc. 17 Sep 2024 6 -$329,691 4 Director 17 Sep 2024, 18:20
KYMR Kymera Therapeutics, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:00
REPL Replimune Group, Inc. 11 Sep 2023 6 -$94,542 4 Chief Business Officer 13 Sep 2023, 22:02
REPL Replimune Group, Inc. 22 Aug 2023 5 -$249,806 4 Chief Business Officer 24 Aug 2023, 21:30
REPL Replimune Group, Inc. 11 Aug 2023 3 -$23,380 4 Chief Business Officer 15 Aug 2023, 21:30
REPL Replimune Group, Inc. 10 Jul 2023 6 -$304,541 4 Chief Business Officer 11 Jul 2023, 21:00
KYMR Kymera Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:15
REPL Replimune Group, Inc. 16 May 2023 1 -$107,686 4 Chief Business Officer 18 May 2023, 20:31
REPL Replimune Group, Inc. 01 Apr 2023 2 $0 4 Chief Business Officer 04 Apr 2023, 20:02
REPL Replimune Group, Inc. 09 Dec 2022 3 -$360,300 4 Chief Business Officer 13 Dec 2022, 19:01
KYMR Kymera Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:06
REPL Replimune Group, Inc. 16 May 2022 1 -$51,167 4 Chief Business Officer 18 May 2022, 19:03
REPL Replimune Group, Inc. 01 Apr 2022 2 $0 4 Chief Business Officer 05 Apr 2022, 16:15
REPL Replimune Group, Inc. 04 Aug 2021 6 -$587,322 4 Chief Business Officer 06 Aug 2021, 21:01
REPL Replimune Group, Inc. 20 Jul 2021 6 -$559,001 4 Chief Business Officer 22 Jul 2021, 21:01
REPL Replimune Group, Inc. 15 Jul 2021 3 -$148,856 4 Chief Business Officer 19 Jul 2021, 21:02
KYMR Kymera Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:50
REPL Replimune Group, Inc. 14 Jan 2021 10 -$2,363,794 4/A Chief Business Officer 19 Jul 2021, 21:02